Related Experiment Video
Updated: Feb 19, 2026
04:30
Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models
Published on: March 8, 2024
1.7K
Sugammadex for Neuromuscular Blockade Reversal
Michelle R Papathanas1, Alley Killian
1Emory University Hospital, Atlanta, Georgia.
Advanced Emergency Nursing Journal
|November 3, 2017
Summary
Sugammadex offers faster and more consistent reversal of neuromuscular blockade than anticholinesterases, reducing respiratory complications. This new agent provides a safer alternative for patients receiving aminosteroidal neuromuscular blockers post-surgery.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Postoperative residual neuromuscular blockade increases risks like respiratory insufficiency and aspiration.
- Current reversal agents, such as neostigmine, have inconsistent efficacy and severe side effects.
Purpose of the Study:
- To evaluate Sugammadex as a novel reversal agent for aminosteroidal neuromuscular blockade.
- To compare the efficacy and safety of Sugammadex against standard anticholinesterase reversal agents.
Main Methods:
- Systematic review and meta-analysis of randomized controlled trials.
- Assessment of reversal time, consistency, and adverse event profiles.
Main Results:
- Sugammadex demonstrated faster and more consistent reversal of neuromuscular blockade.
- Fewer adverse events were reported with Sugammadex compared to anticholinesterases.
Conclusions:
- Sugammadex represents an effective and safer alternative for reversing aminosteroidal neuromuscular blockade.
- The use of Sugammadex may reduce postoperative pulmonary complications associated with residual neuromuscular blockade.
Related Concept Videos
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
1.0K
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
1.0K
01:28Depolarizing Blockers: Mechanism of Action
3.0K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
3.0K
01:31Skeletal Muscle Relaxants: Therapeutic Uses
1.1K
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.1K
01:19Depolarizing Blockers: Pharmocokinetics
622
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
622
01:21Skeletal Muscle Relaxants: Adverse Effects
915
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
915
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
3.1K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
3.1K